The findings obtained in this study will facilitate the genetic counseling and prognosis of patients with CH and will be helpful for clarifying the molecular mechanism underlying CH pathogenesis caused by TPO mutation(s). This evidence concerns the gene TPO and cyclic hematopoiesis.